Alterations of senescence biomarkers in human cells by exposure to CrVI in vivo and in vitro

Experimental Gerontology
Magda KatsikiEfstathios S Gonos

Abstract

Heavy metals like CrVI, CdII, PbII and SnII have many applications in industry. They also represent a group of labour pollutants, as they are involved in several physiological disorders, such as carcinogenesis and various tissue dysfunctions. However, limited knowledge exists regarding their effects on ageing. In the current work we provide evidence that workers chronically exposed to CrVI have considerably reduced serum levels of the biomarker of senescence and cell survival, Apolipoprotein J/Clusterin (ApoJ/CLU). Moreover, we have found that both the degree and the time of exposure to CrVI associate negatively with ApoJ/CLU serum levels. To further examine whether CrVI directly affects cellular senescence we treated for 10 weeks two adult skin fibroblasts cultures as well as embryonic fibroblasts with a range of CrVI concentrations that approximate the values recorded in the blood circulation of exposed workers. Cellular treatment with a CrVI concentration that approximates the highest concentration in the blood was extremely toxic and nearly all cells died immediately after the first treatment. Interestingly, continuous treatment with a 10-fold lower CrVI concentration resulted in the induction of premature senescence. More ...Continue Reading

References

Apr 1, 1991·British Journal of Industrial Medicine·E SugawaraY Seki
Sep 1, 1983·Chemico-biological Interactions·J R McLeanJ G Kaplan
Jan 1, 1981·International Archives of Occupational and Environmental Health·P L KalliomäkiK Aittoniemi
Sep 1, 1994·Environmental Health Perspectives·A Hartwig
May 1, 1994·Toxicology and Industrial Health·O M FaroonR O'Connor
Mar 1, 1993·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·W E Donaldson, S O Knowles
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·Q Chen, B N Ames
Nov 1, 1996·American Journal of Respiratory and Critical Care Medicine·J R BeachD J Hendrick
May 8, 1998·Experimental Cell Research·E S GonosS I Rattan
Feb 8, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·T AdachiX L Wang
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D BarsyteG J Lithgow
Apr 11, 2001·Experimental Gerontology·J Campisi
Oct 20, 2001·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·P BehrensA Wellmann
Oct 9, 2002·Pancreas·Min-Jue XieNorio Sawabu
May 15, 2003·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Violaine VerougstraetePhilippe Hotz
Jun 26, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shin MurakamiRichard A Miller
Nov 18, 2003·International Journal of Cancer. Journal International Du Cancer·Maurizio ScaltritiSaverio Bettuzzi
May 13, 2004·Biogerontology·Niki Chondrogianni, Efstathios S Gonos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis